Sarepta Therapeutics
SRPT
$119.93
Share price
0.32%
Change (1 day)
24.78%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Sarepta Therapeutics (SRPT) - Net assets
Net assets on the balance sheet as of June 2023 : $0.74 B
According to Sarepta Therapeutics
's latest financial reports the company has $0.74 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.38 B | -58.52% |
| 2021-12-31 | $0.92 B | 21.82% |
| 2020-12-31 | $0.76 B | -6.9% |
| 2019-12-31 | $0.81 B | -20.74% |
| 2018-12-31 | $1.03 B | 30.8% |
| 2017-12-31 | $0.78 B | 134.4% |
| 2016-12-31 | $0.33 B | 76.88% |
| 2015-12-31 | $0.19 B | -23.14% |
| 2014-12-31 | $0.24 B | 0.19% |
| 2013-12-31 | $0.24 B | 99.87% |
| 2012-12-31 | $0.12 B | 298.75% |
| 2011-12-31 | $31.01 M | -1201.06% |
| 2010-12-31 | $-2.82 M | -111.92% |
| 2009-12-31 | $23.63 M | 50.2% |
| 2008-12-31 | $15.73 M | -40.37% |
| 2007-12-31 | $26.38 M | -30.04% |
| 2006-12-31 | $37.71 M | -29.72% |
| 2005-12-31 | $53.66 M | 104.27% |
| 2004-12-31 | $26.26 M | -39.46% |
| 2003-12-31 | $43.39 M | 84.8% |
| 2002-12-31 | $23.48 M | -23.1% |
| 2001-12-31 | $30.53 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $21.09 B | 2,745.12% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.58 B | -178.13% | 🇺🇸 USA |
 Novavax NVAX | -$0.76 B | -201.77% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.41 B | -155.05% | 🇺🇸 USA |
 Insmed INSM | -$0.16 B | -121.01% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.39 B | -152.43% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.55 B | -24.58% | 🇺🇸 USA |